Ikarian-Capital

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AKRO",
  "EWTX",
  "TRVI",
  "NKTR",
  "INSM",
  "FBRX",
  "TGTX",
  "APLS",
  "ALNY",
  "ARCT",
  "DNA",
  "SWTX",
  "RCKT",
  "SGMO",
  "ARVN",
  "ALT",
  "RCUS",
  "OLMA",
  "GPCR",
  "RLAY",
  "THRD",
  "TERN",
  "TRML",
  "NUVB",
  "TYRA",
  "MNMD",
  "TECX",
  "LRMR",
  "MLYS",
  "KYMR",
  "NMRA",
  "ABEO",
  "KROS",
  "GLUE",
  "PRTA",
  "ABOS",
  "ANRO",
  "ALEC",
  "ALLK",
  "AVTX",
  "JANX",
  "ANEB",
  "PHGE",
  null,
  "GERN",
  "SRRK",
  "FULC",
  "APGE",
  "TARS",
  "TKNO",
  "INBX",
  "JSPR",
  "MGNX",
  "LXEO",
  "LYEL",
  null,
  "MNPR",
  null,
  "STIM",
  "OKUR",
  "PYXS",
  "RLMD",
  "SGMT",
  "SNSE",
  "SYBX",
  "CYBN",
  null,
  "AEMD",
  "TOVX",
  "RZLT",
  "ACRS",
  "ACOG",
  "INCY",
  "TEVA",
  "SPY",
  "PTGX",
  "PEPG",
  "TRAW",
  "RNA",
  "SLDB",
  "PRAX",
  "LXRX",
  "LYRA",
  "MLTX",
  "IBIO",
  "EVAX",
  "SLNO",
  "ACLX",
  "QURE",
  "RNAC",
  "ETNB",
  "DYN",
  "SPRB",
  "SRPT",
  "CHRO",
  null,
  null,
  "CRVS",
  "CDTX",
  "ELDN",
  "ELEV",
  "ELVN",
  "DCTH",
  "EOLS",
  "IMUX",
  "HROW",
  "HOOK",
  "ITOS",
  "KPTI",
  "KOD",
  "KZR",
  "VRNA",
  "VERU",
  "VTYX",
  "VERV",
  "VTGN",
  "VKTX",
  "VIR",
  "VIGL",
  "VRDN",
  "VYGR",
  "ORKA",
  "BHVN",
  "TRUP",
  "TDOC",
  "RARE",
  "IMVT",
  "PCVX",
  "BPMC",
  "BBIO",
  "CAPR",
  "CELC",
  "CPRX",
  "CLDX",
  "CMPX",
  "CORT",
  "CRNX",
  "CPIX",
  "CYTK",
  "IRON",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 141
Total Value: 710178588
Accession Number: 0001420506-25-001276
Form Type: 13F-HR
CIK: ikarian-capital
Manager Name: Ikarian-Capital

Data Enrichment

96% identified

135 identified6 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

141 positions • $710.2M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 5 of 8

Sort by:

Corvus Pharmaceuticals, Inc.

CRVS|221015100

Shares:338.1K

Value:$1.1M

% of Portfolio:0.2% ($1.1M/$710.2M)

NEKTAR THERAPEUTICS

NKTR|640268108

Shares:1.6M

Value:$1.1M

% of Portfolio:0.2% ($1.1M/$710.2M)

Tourmaline Bio, Inc.

TRML|89157D105

Shares:67.9K

Value:$1.0M

% of Portfolio:0.1% ($1.0M/$710.2M)

Terns Pharmaceuticals, Inc.

TERN|880881107

Shares:308.5K

Value:$851.4K

% of Portfolio:0.1% ($851.4K/$710.2M)

Solid Biosciences Inc.

SLDB|83422E204

Shares:230.0K

Value:$851.0K

% of Portfolio:0.1% ($851.0K/$710.2M)

89bio, Inc.

ETNB|282559103

Shares:100.0K

Value:$727.0K

% of Portfolio:0.1% ($727.0K/$710.2M)

Olema Pharmaceuticals, Inc.

OLMA|68062P106

Shares:192.0K

Value:$721.9K

% of Portfolio:0.1% ($721.9K/$710.2M)

VERU INC.

VERU|92536C103

Shares:1.4M

Value:$698.5K

% of Portfolio:0.1% ($698.5K/$710.2M)

IMMUNIC, INC.

IMUX|4525EP101

Shares:635.8K

Value:$693.0K

% of Portfolio:0.1% ($693.0K/$710.2M)

LEXICON PHARMACEUTICALS, INC.

LXRX|528872302

Shares:1.4M

Value:$653.4K

% of Portfolio:0.1% ($653.4K/$710.2M)

Monte Rosa Therapeutics, Inc.

GLUE|61225M102

Shares:136.6K

Value:$633.7K

% of Portfolio:0.1% ($633.7K/$710.2M)

Channel Therapeutics Corp

CHRO|171126105

Shares:440.8K

Value:$626.0K

% of Portfolio:0.1% ($626.0K/$710.2M)

Pyxis Oncology, Inc.

PYXS|747324101

Shares:613.3K

Value:$600.9K

% of Portfolio:0.1% ($600.9K/$710.2M)

Disc Medicine, Inc.

IRON|254604101

Shares:11.9K

Value:$590.7K

% of Portfolio:0.1% ($590.7K/$710.2M)

Inhibrx Biosciences, Inc.

INBX|45720N103

Shares:42.1K

Value:$589.3K

% of Portfolio:0.1% ($589.3K/$710.2M)

Fulcrum Therapeutics, Inc.

FULC|359616109

Shares:200.1K

Value:$576.3K

% of Portfolio:0.1% ($576.3K/$710.2M)

SpringWorks Therapeutics, Inc.

SWTX|85205L107

Shares:12.5K

Value:$552.5K

% of Portfolio:0.1% ($552.5K/$710.2M)

Mineralys Therapeutics, Inc.

MLYS|603170101

Shares:34.3K

Value:$544.7K

% of Portfolio:0.1% ($544.7K/$710.2M)

Kezar Life Sciences, Inc.

KZR|49372L209

Shares:106.9K

Value:$521.7K

% of Portfolio:0.1% ($521.7K/$710.2M)

BiomX Inc.

PHGE|09090D301

Shares:893.0K

Value:$496.2K

% of Portfolio:0.1% ($496.2K/$710.2M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Corvus Pharmaceuticals, Inc.(CRVScusip221015100)	338.1K	QoQ -55.18% (-416.3K) YoY NEW(+338.1K)	All Managers (Combined)	$1.1M	0.2% ($1.1M/$710.2M)	QoQ -73.36% (-$3.0M) YoY NEW(+$1.1M)
NEKTAR THERAPEUTICS(NKTRcusip640268108)	1.6M	QoQ -22.15% (-449.5K) YoY NEW(+1.6M)	All Managers (Combined)	$1.1M	0.2% ($1.1M/$710.2M)	QoQ -43.07% (-$812.9K) YoY NEW(+$1.1M)
Tourmaline Bio, Inc.(TRMLcusip89157D105)	67.9K	QoQ 0.00% (-0) YoY -62.09% (-111.3K)	All Managers (Combined)	$1.0M	0.1% ($1.0M/$710.2M)	QoQ -24.99% (-$344.4K) YoY -74.82% (-$3.1M)
Terns Pharmaceuticals, Inc.(TERNcusip880881107)	308.5K	QoQ 0.00% (-0) YoY +248.58% (+220.0K)	All Managers (Combined)	$851.4K	0.1% ($851.4K/$710.2M)	QoQ -50.18% (-$857.6K) YoY +46.66% (+$270.9K)
Solid Biosciences Inc.(SLDBcusip83422E204)	230.0K	QoQ -23.33% (-70.0K) YoY NEW(+230.0K)	All Managers (Combined)	$851.0K	0.1% ($851.0K/$710.2M)	QoQ -29.08% (-$349.0K) YoY NEW(+$851.0K)
89bio, Inc.(ETNBcusip282559103)	100.0K	QoQ NEW(+100.0K) YoY NEW(+100.0K)	All Managers (Combined)	$727.0K	0.1% ($727.0K/$710.2M)	QoQ NEW(+$727.0K) YoY NEW(+$727.0K)
Olema Pharmaceuticals, Inc.(OLMAcusip68062P106)	192.0K	QoQ +108.70% (+100.0K) YoY NEW(+192.0K)	All Managers (Combined)	$721.9K	0.1% ($721.9K/$710.2M)	QoQ +34.60% (+$185.6K) YoY NEW(+$721.9K)
VERU INC.(VERUcusip92536C103)	1.4M	QoQ +50.78% (+480.0K) YoY +50.59% (+478.9K)	All Managers (Combined)	$698.5K	0.1% ($698.5K/$710.2M)	QoQ +13.60% (+$83.6K) YoY +5.42% (+$35.9K)
IMMUNIC, INC.(IMUXcusip4525EP101)	635.8K	QoQ -60.61% (-978.4K) YoY -60.56% (-976.6K)	All Managers (Combined)	$693.0K	0.1% ($693.0K/$710.2M)	QoQ -57.06% (-$921.1K) YoY -67.43% (-$1.4M)
LEXICON PHARMACEUTICALS, INC.(LXRXcusip528872302)	1.4M	QoQ -8.51% (-132.0K) YoY NEW(+1.4M)	All Managers (Combined)	$653.4K	0.1% ($653.4K/$710.2M)	QoQ -42.91% (-$491.3K) YoY NEW(+$653.4K)
Monte Rosa Therapeutics, Inc.(GLUEcusip61225M102)	136.6K	QoQ -56.16% (-175.0K) YoY NEW(+136.6K)	All Managers (Combined)	$633.7K	0.1% ($633.7K/$710.2M)	QoQ -70.69% (-$1.5M) YoY NEW(+$633.7K)
Channel Therapeutics Corp(CHROcusip171126105)	440.8K	QoQ NEW(+440.8K) YoY NEW(+440.8K)	All Managers (Combined)	$626.0K	0.1% ($626.0K/$710.2M)	QoQ NEW(+$626.0K) YoY NEW(+$626.0K)
Pyxis Oncology, Inc.(PYXScusip747324101)	613.3K	QoQ 0.00% (-0) YoY -63.11% (-1.0M)	All Managers (Combined)	$600.9K	0.1% ($600.9K/$710.2M)	QoQ -37.18% (-$355.7K) YoY -91.51% (-$6.5M)
Disc Medicine, Inc.(IRONcusip254604101)	11.9K	QoQ NEW(+11.9K) YoY -76.00% (-37.7K)	All Managers (Combined)	$590.7K	0.1% ($590.7K/$710.2M)	QoQ NEW(+$590.7K) YoY -80.87% (-$2.5M)
Inhibrx Biosciences, Inc.(INBXcusip45720N103)	42.1K	QoQ 0.00% (-0) YoY NEW(+42.1K)	All Managers (Combined)	$589.3K	0.1% ($589.3K/$710.2M)	QoQ -9.15% (-$59.4K) YoY NEW(+$589.3K)
Fulcrum Therapeutics, Inc.(FULCcusip359616109)	200.1K	QoQ 0.00% (-0) YoY NEW(+200.1K)	All Managers (Combined)	$576.3K	0.1% ($576.3K/$710.2M)	QoQ -38.72% (-$364.2K) YoY NEW(+$576.3K)
SpringWorks Therapeutics, Inc.(SWTXcusip85205L107)	12.5K	QoQ -66.63% (-25.0K) YoY NEW(+12.5K)	All Managers (Combined)	$552.5K	0.1% ($552.5K/$710.2M)	QoQ -59.24% (-$803.1K) YoY NEW(+$552.5K)
Mineralys Therapeutics, Inc.(MLYScusip603170101)	34.3K	QoQ -89.68% (-298.1K) YoY NEW(+34.3K)	All Managers (Combined)	$544.7K	0.1% ($544.7K/$710.2M)	QoQ -86.68% (-$3.5M) YoY NEW(+$544.7K)
Kezar Life Sciences, Inc.(KZRcusip49372L209)	106.9K	QoQ 0.00% (-0) YoY NEW(+106.9K)	All Managers (Combined)	$521.7K	0.1% ($521.7K/$710.2M)	QoQ -27.38% (-$196.7K) YoY NEW(+$521.7K)
BiomX Inc.(PHGEcusip09090D301)	893.0K	QoQ 0.00% (-0) YoY NEW(+893.0K)	All Managers (Combined)	$496.2K	0.1% ($496.2K/$710.2M)	QoQ -23.88% (-$155.7K) YoY NEW(+$496.2K)